Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma

Cancer

Volumn 89, Issue 4, 2000, Pages 715-723

  Horikawa, Toshiyuki ^a   Yoshizaki, Tomokazu ^a   Sheen, Tzung Shiahn ^b   Lee, Shiann Yann ^b   Furukawa, Mitsuru ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Epstein Barr virus; Immunohistochemistry; Latent membrane protein 1; Lymph node metastasis; Matrix metalloproteinase 9; Nasopharyngeal Carcinoma

Indexed keywords

GELATINASE B; LATENT MEMBRANE PROTEIN 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 0034663173     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000815)89:4<715::AID-CNCR1>3.0.CO;2-9     Document Type: Article

References (39)

1. Tumors of the pharynx
2. EBV associated malignancies
3. Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis
4. Epstein-Barr virus-increasing evidence of a link to carcinoma
5. Epstein-Barr virus gene expression in nasopharyngeal carcinoma
6. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation: Fibroblast cocultivation complements a critical function within the terminal 155 residues
7. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
8. Biologic diversity in metastatic neoplasms-origins and implications
9. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
10. Tumor invasion and metastasis: An imbalance of positive and negative regulation
11. Tumor invasion and metastasisrole of the extracellular matrix: Rhoads memorial award lecture
12. Metalloproteinase in tumor progression: The contribution of MMP-9
13. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression
14. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma
15. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis
16. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer
17. Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression
18. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis
19. Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas
20. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1
21. Use of avidin-biotin-peroxidase complex (ABC) in immuno peroxidase technique: A comparison between ABC and unlabeled antibody (PAP) procedure
22. Associations of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma
23. Expression of Epstein-Barr virus encoded proteins in nasopharyngeal carcinoma
24. Type IV collagenases in invasive tumors
25. The Epstein-Barr virus latent membrane protein 1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain
26. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1)
27. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2
28. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma
29. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line
30. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
31. Expressions of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells
32. v-Sarc activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines
33. Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator
34. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression
35. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein-1 protects infected B cells from programmed cell death
36. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor
37. Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells
38. Downregulation and abnormal expressions of E-cadherin and beta-catenin in nasopharyngeal carcinoma: Close association with advanced disease stage and lymph node metastasis
39. Expression of Epstein-Barr virus related factors and angiogenetic factors in nasopharyngeal carcinomas